Kelly R. Carr

Senior Associate

  • Kelly R. Carr
  • Phone: +1 212 471 1870

    Import to Address Book

  • Duane Morris LLP
    22 Vanderbilt
    335 Madison Avenue, 23rd Floor
    New York, NY 10017-4669
    USA

Kelly R. Carr is a senior associate in the Corporate Practice Group at Duane Morris LLP, where she advises public companies and financial institutions on capital markets transactions, securities law matters and corporate governance issues.

Kelly's practice focuses on helping companies raise capital through a broad range of financing structures, including ATM programs, registered direct offerings, confidentially marketed public offerings and PIPE transactions. She also advises clients on SEC reporting and disclosure obligations, stock exchange compliance, corporate governance matters and other ongoing public company responsibilities.

She has advised issuers and financial institutions on transactions across a broad range of industries, including the life sciences, energy, technology and real estate sectors, helping public companies access capital efficiently while navigating evolving regulatory and market requirements.

In 2025, Kelly was part of the Duane Morris team that represented Monogram Technologies in its acquisition by Zimmer Biomet, a transaction recognized by M&A Magazine with an honorable mention in the healthcare category. The transaction combined a pioneering robotics platform with one of the world's leading orthopedic medical technology companies and reflected the growing convergence of healthcare innovation and strategic M&A activity.

Kelly is known for her practical approach to transactions and her ability to coordinate sophisticated financings and strategic transactions involving multiple stakeholders under demanding timelines. She works closely with management teams, boards of directors, investment banks and other transaction participants to execute complex transactions in dynamic market environments.

Kelly received her J.D. from Fordham University School of Law in 2018 and her B.S. from Syracuse University in 2015. She is admitted to practice in New York.

Admissions

  • New York

Education

  • Fordham University School of Law, J.D., 2018
  • Syracuse University, B.S., 2015

Experience

  • Duane Morris LLP
    - Senior Associate, 2025-present
    - Associate, 2021-2024
  • Sidley Austin LLP
    - Associate, 2018-2021

Representative Matters

  • Represented Jefferies LLC, Piper Sandler & Co. and Guggenheim Securities LLC as representatives of the several underwriters in a confidentially marketed public offering with Compass Therapeutics Inc. The parties entered into an underwriting agreement, pursuant to which Compass agreed to issue and sell an aggregate of 33.29 million shares of its common stock at a price to the public of $3 per share and pre-funded warrants to purchase up to 6.71 million shares of its common stock at a price to the public of $2.9999 per warrant with an exercise price of $0.0001 per share. Compass also granted the underwriters a 30-day option to purchase up to an additional 6 million shares of its common stock which the clients exercised in full on behalf of the underwriters.

  • Represented B. Riley Securities Inc. and Citigroup Global Markets Inc. as underwriters in a headline-making at-the-market transaction involving AMC Entertainment Holdings Inc. in which nearly $40 billion worth of AMC shares changed hands on Wall Street.

  • Represented Four Springs Capital Trust, a private REIT, in connection with Carlyle’s Global Credit platform’s financing up to $300 million in growth capital; Four Springs plans to use the funds to scale its portfolio that includes 122 properties across 29 states.

  • Represented JonesTrading Institutional Services LLC, acting as sales agent in a $150 million at the market equity offering of common stock for Overstock.com, Inc. (NASDAQ: OSTK), the online retailer and advancer of blockchain technology.

  • Represented Protagenic Therapeutics, Inc. (Nasdaq: PTIX), a pre-clinical biopharmaceutical company developing treatments for stress-related disorders, in its $13.2 million initial public offering and subsequent Nasdaq listing.

  • Advised the client regarding a free to play app where participants participate in weekly contests for prize money selecting results in NFL games, NASCAR, PGA Golf and English Premier League.

  • Represented H.C. Wainwright & Co., LLC, acting as sales agent in a $30 million at the market equity offering of common stock for XOMA Corp. (NASDAQ: RGLS). XOMA engages in the discovery, development, and licensing of innovative therapeutics derived from a unique platform of antibody technologies.